(Cost-)effectiveness of optical coherence tomography versus regular punch biopsy in the diagnosis and subtyping of basal cell carcinoma: a multi-center randomized non-inferiority trial
Completed
- Conditions
- Basal cell carcinomaskin cancer10040900
- Registration Number
- NL-OMON48208
- Lead Sponsor
- Medisch Universitair Ziekenhuis Maastricht
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 598
Inclusion Criteria
In order to be eligible to participate in this study, a subject must meet the following criteria:
- Adult patient (>18 years)
- Clinical and dermoscopic suspicion of basal cell carcinoma (BCC)
- BCC is in the differential diagnosis and a biopsy would normally be obtained to confirm the diagnosis and subtype or exclude other skin lesions.
Exclusion Criteria
A potential subject who meets any of the following criteria will be excluded from participation in this study:
- Patients with BCC in the high-risk zone of the face (ear, nose, eye region)
- Patients with a large BCC referred to our (tertiary care) head and neck tumour working group.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method